Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 15Parkinson Disease 4, Autosomal Dominant Lewy Body 2Metastatic Hormone-sensitive Prostate Cancer 2Urogenital Neoplasms 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Hormone Sensitive Prostate Cancer 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Metastatic Castrate-sensitive Prostate Cancer 1Genital Neoplasms, Male 1

Interventions

apalutamide 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Metastatic Castrate-sensitive Prostate Cancer × Androgen Antagonists × Clear all
NCT05884398 2026-06-05

LIBERTAS

Janssen Research & Development, LLC

Phase 3 Active not recruiting
420 enrolled
Genitourinary

Metastatic Castrate-sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡